FSLBX
Price
$167.23
Change
-$0.43 (-0.26%)
Updated
Jun 22 closing price
Net Assets
941.07M
ICFSX
Price
$8.92
Change
+$0.02 (+0.22%)
Updated
Jun 22 closing price
Net Assets
25.65M
Interact to see
Advertisement

FSLBX vs ICFSX

FSLBX vs ICFSX Comparison Chart in %
View a ticker or compare two or three
VS
FSLBX vs. ICFSX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLBX is a Hold and ICFSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSLBX has more cash in the bank: 941M vs. ICFSX (25.7M). FSLBX pays higher dividends than ICFSX: FSLBX (0.72) vs ICFSX (0.11). FSLBX was incepted earlier than ICFSX: FSLBX (41 years) vs ICFSX (29 years). ICFSX (1.47) is less costly to investors than FSLBX (0.66). ICFSX is a more actively managed with annual turnover of: 28.00 vs. FSLBX (10.00). FSLBX has a lower initial minimum investment than ICFSX: FSLBX (0) vs ICFSX (1000). ICFSX annual gain was more profitable for investors over the last year : -5.50 vs. FSLBX (-7.77). FSLBX return over 5 years is better than : 51.40 vs. ICFSX (-29.40).
FSLBXICFSXFSLBX / ICFSX
Total Expense Ratio0.661.4745%
Annual Report Gross Expense Ratio0.661.4745%
Fund Existence41 years29 years-
Gain YTD-12.174-3.463352%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets941M25.7M3,661%
Annual Yield % from dividends0.720.11668%
Returns for 1 year-7.77-5.50141%
Returns for 3 years58.96-8.89-663%
Returns for 5 years51.40-29.40-175%
Returns for 10 years227.6330.62743%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICEUX54.570.06
+0.11%
NYLI Epoch International Choice Class I
JEMSX56.18N/A
N/A
JPMorgan Emerging Markets Equity I
NMMGX11.10N/A
N/A
Northern Multi-Manager Glbl Real Estate
LOGWX46.71N/A
N/A
Lord Abbett Developing Growth F3
PXSCX21.27-0.03
-0.14%
Impax Small Cap Investor